Oracle acquisition of software firm will pump up its portfolio

04/19/2010 | Boston Globe (tiered subscription model), The

Oracle plans to augment its drug research software portfolio by acquiring Phase Forward, a firm that offers clinical trial management software. The $685 million deal should close by mid-year and will bring together "some of the best-of-breed products into one solution," an official from IDC Health Insights said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA